Sign In

Ben Woodington

Co-founder of Opto.bio with expertise in bioelectronics and neural interfaces

Ben Woodington is the CEO and co-founder of Opto Biosystems, a bioelectronics start-up focused on developing minimally invasive neural interfaces aimed at treating neurological diseases. He has been in this role since May 2022, leading the company's mission to innovate in the field of neurotechnology and improve treatment options for challenging medical conditions such as brain cancer and epilepsy.123

Education and Background

Woodington completed his PhD in Bioelectronics at the University of Cambridge, where he specialized in developing flexible and shape-adaptive neural interfaces for sensing and stimulating the central nervous system.13 His academic journey also includes a Master of Research in Sensor Technologies and Applications and a Bachelor of Science in Chemistry from the University of Surrey.13

Before founding Opto Biosystems, he worked in various engineering and scientific roles, including positions at Vectura Group plc, where he contributed to the development and commercialization of medical devices.13 His experience in medical device engineering and bioelectronics research has been pivotal in translating his academic work into practical applications in healthcare.

Vision and Impact

Woodington's work at Opto aims to revolutionize how neurological diseases are treated by creating implantable, miniaturized sensors that can provide real-time monitoring of brain activity without the need for major surgery.23 The technology is designed to be less invasive, potentially allowing for outpatient procedures and improving patient outcomes in the treatment of serious conditions.23

Under his leadership, Opto Biosystems has garnered attention and funding, including £1.85 million in pre-seed funding to further develop its innovative technologies.24 Woodington's commitment to advancing bioelectronics reflects his belief in the transformative potential of technology in medicine, particularly in providing better tools for clinicians and improving patient care.3

Highlights

Jun 25 · youtube.com
Embracing bioelectronics to improve lives, with Opto - YouTube
Embracing bioelectronics to improve lives, with Opto - YouTube
Apr 28 · eng.cam.ac.uk
Introducing Opto – the start-up pushing new frontiers in medicine
Opto Biosystems launches with £1.85 million pre-seed funding ...
Aug 3 · eng.cam.ac.uk
PhD students' bioelectronics start-up wins enterprise competition
PhD students' bioelectronics start-up wins enterprise competition

Related Questions

What inspired Ben Woodington to co-found Opto Biosystems?
How does Ben Woodington's background in bioelectronics influence his leadership at Opto Biosystems?
What are the main challenges Ben Woodington faces as CEO of Opto Biosystems?
How does Opto Biosystems' technology compare to other neural interface technologies?
What are Ben Woodington's future plans for Opto Biosystems?
Ben Woodington
Ben Woodington, photo 1
Ben Woodington, photo 2
Add to my network

Experience

CEO + Co-Founder at Opto Biosystems since May 2022
PhD Candidate at University of Cambridge from October 2018 to February 2023, Lead Engineer - NPI at Vectura Group plc. from July 2018 to November 2018, Lead Scientist at Vectura Group plc. from May 2018 to July 2018, Pharmaceutical Technology Scientist at Vectura Group plc. from June 2016 to May 2018, Associate Scientist at Vectura Group plc. from October 2015 to June 2016, Aerosol Scientist (medical devices) at Philips from September 2012 to September 2013

Education

Doctor of Philosophy - PhD, Bioelectronics at University of Cambridge from 2019 to 2022, EnterpriseTECH Star Programme at Cambridge Judge Business School from 2019 to 2020, Distinction, EnterpriseTECH PhD+ at Cambridge Judge Business School from 2018 to 2019, Master of Research (MRes), Sensor Technologies and Applications at University of Cambridge from 2018 to 2019, Bachelor of Science (BSc), Chemistry at University of Surrey from 2010 to 2014

Location

Greater Cambridge Area